Point72 Asset Management L.P. bought a new stake in shares of DBV Technologies SA – (NASDAQ:DBVT) during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund bought 51,600 shares of the company’s stock, valued at approximately $2,190,000. Point72 Asset Management L.P. owned approximately 0.10% of DBV Technologies at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently made changes to their positions in the company. Jennison Associates LLC boosted its stake in DBV Technologies by 86.4% during the second quarter. Jennison Associates LLC now owns 1,002,067 shares of the company’s stock worth $35,784,000 after acquiring an additional 464,341 shares in the last quarter. Airain ltd bought a new stake in DBV Technologies during the second quarter worth about $333,000. Sectoral Asset Management Inc boosted its stake in DBV Technologies by 34.2% during the second quarter. Sectoral Asset Management Inc now owns 179,152 shares of the company’s stock worth $6,398,000 after acquiring an additional 45,653 shares in the last quarter. Janus Henderson Group PLC bought a new stake in DBV Technologies during the second quarter worth about $90,724,000. Finally, Dynamic Technology Lab Private Ltd bought a new stake in DBV Technologies during the second quarter worth about $222,000. 46.92% of the stock is currently owned by hedge funds and other institutional investors.

DBVT has been the topic of several research reports. Deutsche Bank boosted their price objective on shares of DBV Technologies from $46.00 to $56.00 in a research note on Sunday, October 8th. Zacks Investment Research raised shares of DBV Technologies from a “hold” rating to a “buy” rating and set a $32.00 price objective on the stock in a research note on Tuesday, October 24th. Morgan Stanley reissued an “overweight” rating and set a $72.00 price objective (up previously from $70.00) on shares of DBV Technologies in a research note on Friday, October 6th. JMP Securities initiated coverage on shares of DBV Technologies in a research note on Friday, November 17th. They set an “outperform” rating on the stock. Finally, Leerink Swann set a $49.00 price objective on shares of DBV Technologies and gave the stock an “outperform” rating in a research note on Monday, October 23rd. Two investment analysts have rated the stock with a sell rating, three have issued a hold rating and eight have assigned a buy rating to the company. DBV Technologies has an average rating of “Hold” and an average target price of $49.63.

DBV Technologies SA – (NASDAQ:DBVT) opened at $23.79 on Thursday. DBV Technologies SA – has a 52 week low of $20.58 and a 52 week high of $50.57.

COPYRIGHT VIOLATION NOTICE: “Point72 Asset Management L.P. Buys New Position in DBV Technologies SA – (DBVT)” was originally posted by Watch List News and is the property of of Watch List News. If you are reading this article on another website, it was stolen and republished in violation of U.S. and international copyright & trademark law. The legal version of this article can be viewed at https://www.watchlistnews.com/point72-asset-management-l-p-buys-new-position-in-dbv-technologies-sa-dbvt/1775528.html.

About DBV Technologies

DBV Technologies SA is a France-based clinical-stage biopharmaceutical company focused on changing the field of immunotherapy by developing a technology platform called Vaskin. The Company’s therapeutic approach is based on epicutaneous immunotherapy, or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin.

Institutional Ownership by Quarter for DBV Technologies (NASDAQ:DBVT)

Receive News & Ratings for DBV Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DBV Technologies and related companies with MarketBeat.com's FREE daily email newsletter.